云顶新耀(01952)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01952 云顶新耀

未开盘 12-31 12:08:29

36.980

-0.880

-2.32%

最高38.300	最低36.700	成交量334.70万
今开37.980	昨收37.860	日振幅4.23%
总市值130.91亿	流通市值130.91亿	总股本3.54亿
成交额1.25亿	换手率0.95%	流通股本3.54亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01952","market":"HK","secType":"STK","nameCN":"云顶新耀","latestPrice":36.98,"timestamp":1767154109003,"preClose":37.86,"halted":0,"volume":3347000,"delay":0,"floatShares":354000000,"shares":354000000,"eps":-3.6195024155600533,"marketStatus":"未开盘","change":-0.88,"latestTime":"12-31 12:08:29","open":37.98,"high":38.3,"low":36.7,"amount":124512825,"amplitude":0.042261,"askPrice":37.08,"askSize":1500,"bidPrice":36.98,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-2.273159785436289,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1767317400000},"marketStatusCode":0,"adr":0,"listingDate":1602172800000,"exchange":"SEHK","adjPreClose":37.86,"openAndCloseTimeList":[[1767144600000,1767153600000]],"volumeRatio":1.030281912960233,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01952","defaultTab":"news","newsList":[{"id":"2595506727","title":"云顶新耀(01952)获董事会主席吴以芳增持3万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2595506727","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595506727?lang=zh_cn&edition=full","pubTime":"2025-12-31 17:04","pubTimestamp":1767171862,"startTime":"0","endTime":"0","summary":"智通财经APP讯，云顶新耀(01952)发布公告，于2025年12月31日，公司执行董事兼董事会主席吴以芳先生于市场购入3万股公司普通股，总代价约为113.9万港元，平均价格约为每股股份37.98港元。董事会相信，吴先生透过场内收购股份进行的自愿购股彰显了对公司未来前景及长远发展的坚定信心。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1387746.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01952","BK1574","BK1583","BK1161"],"gpt_icon":0},{"id":"2600883280","title":"每日卖空追踪 | 云顶新耀 12月31日卖空量成交18.1万股，卖空比例为5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2600883280","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600883280?lang=zh_cn&edition=full","pubTime":"2025-12-31 16:30","pubTimestamp":1767169826,"startTime":"0","endTime":"0","summary":"云顶新耀北京时间12月31日，跌2.32%，卖空量成交18.1万股，较上一交易日减少33.82%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231163345a48dc6bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231163345a48dc6bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","01952","BK1583","BK1161"],"gpt_icon":0},{"id":"2595772515","title":"从“年度创新力奖”看云顶新耀（01952.HK）：以“双轮驱动”构建可持续创新体系","url":"https://stock-news.laohu8.com/highlight/detail?id=2595772515","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595772515?lang=zh_cn&edition=full","pubTime":"2025-12-31 14:09","pubTimestamp":1767161390,"startTime":"0","endTime":"0","summary":"云顶新耀的2025年，不仅是一家企业的价值重估之路，更是中国创新药发展逻辑深刻转型的生动缩影。","market":"us","thumbnail":"https://img2.gelonghui.com/b17e2-851750a5-e14a-4a79-a024-38dd62ed4065.jpg?guru_height=720&guru_width=1280&guru_size=154189","type":0,"news_type":0,"thumbnails":["https://img2.gelonghui.com/b17e2-851750a5-e14a-4a79-a024-38dd62ed4065.jpg?guru_height=720&guru_width=1280&guru_size=154189"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/3477313","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["01952","BK1161","BK1583","BK1574"],"gpt_icon":0},{"id":"2595713426","title":"港股公告掘金 | 云顶新耀：原研产品耐赋康®的相关技术在中国受到专利ZL200980127272.5的保护，该专利目前处于有效状态","url":"https://stock-news.laohu8.com/highlight/detail?id=2595713426","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595713426?lang=zh_cn&edition=full","pubTime":"2025-12-30 22:55","pubTimestamp":1767106552,"startTime":"0","endTime":"0","summary":"重大事项：云顶新耀(01952)：原研产品耐赋康的相关技术在中国受到专利ZL200980127272.5的保护，该专利目前处于有效状态联康生物科技集团(00690)与温医大国家工程研究中心及温州市瓯海区人民政府达成战略合作和黄医药(00013)宣布赛沃替尼 (savolitinib) 用于治疗伴有MET扩增的胃癌患者的中国新药上市申请获受理并获纳入优先审评复星医药(02196)控股子公司就诊疗一体","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1387378.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01952","00690","BK1515","BK1191","BK1593","BK1587","BK1588","00013","BK1574","BK1583","02196"],"gpt_icon":0},{"id":"2595791257","title":"每日卖空追踪 | 云顶新耀 12月30日卖空量成交19.7万股，卖空比例为4.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595791257","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595791257?lang=zh_cn&edition=full","pubTime":"2025-12-30 16:30","pubTimestamp":1767083425,"startTime":"0","endTime":"0","summary":"云顶新耀北京时间12月30日，跌0.21%，卖空量成交19.7万股，较上一交易日减少83.02%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230163335a4897e3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230163335a4897e3a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01952","BK1583","BK1574","BK1161"],"gpt_icon":0},{"id":"2595791226","title":"云顶新耀12月30日遭主力抛售523.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2595791226","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595791226?lang=zh_cn&edition=full","pubTime":"2025-12-30 16:16","pubTimestamp":1767082561,"startTime":"0","endTime":"0","summary":"12月30日, 云顶新耀股价跌0.21%，报收37.86元，成交金额1.9亿元，换手率1.38%，振幅3.74%，量比0.70。云顶新耀今日主力资金净流出523.7万元，连续5日净流出，上一交易日主力净流出1779.6万元。近一年数据显示，该股主力连续5日净流出后，次日下跌概率为66.67%，平均跌幅为3.93%。该股近5个交易日下跌22.97%，主力资金累计净流出3517.0万元；近20日主力资金累计净流出182.6万元，其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230162318a489726f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230162318a489726f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","01952","BK1161","BK1574"],"gpt_icon":0},{"id":"2595420165","title":"港股医药股午后持续走低，云顶新耀跌超10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595420165","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595420165?lang=zh_cn&edition=full","pubTime":"2025-12-29 13:19","pubTimestamp":1766985580,"startTime":"0","endTime":"0","summary":"南方财经12月29日电，港股医药股午后持续走低，云顶新耀跌超10%，药捷安康-B跌超8%，先声药业跌超6%，科伦博泰生物-B、复星医药纷纷下挫。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512293604336445.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","01952","159718","BK1583","BK1161"],"gpt_icon":0},{"id":"1102493660","title":"一周港股牛熊榜 | AI材料与有色爆发！中铝国际暴涨20.6%、力勤资源暴涨18.6%、中伟新材大涨16%；因股份解禁，周六福暴跌24.9%、药捷安康暴跌20.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1102493660","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102493660?lang=zh_cn&edition=full","pubTime":"2025-12-26 16:46","pubTimestamp":1766738819,"startTime":"0","endTime":"0","summary":"24日镍概念集体走高，力勤资源、中伟新材、新疆新鑫矿业均涨幅近 9%。12月23日，周六福在港交所公告，董事会注意到公司H股价格近期出现不寻常波动。根据数据，此次药捷安康共计5名股东发生解禁，累计解禁股数达977.4万股，占比约2.46%。23日跌超18%、24日继续跌5.8%。","market":"hk","thumbnail":"https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03939","06821","HSI","02268","HSCEI","02617","02315","02245","06168","02068","01952","HSTECH","02579"],"gpt_icon":1},{"id":"2594252445","title":"智通港股通占比异动统计|12月26日","url":"https://stock-news.laohu8.com/highlight/detail?id=2594252445","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594252445?lang=zh_cn&edition=full","pubTime":"2025-12-26 08:35","pubTimestamp":1766709358,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，根据2025年12月24日披露数据，中通快递-Ｗ、MONGOLIAN MINING CORPORATION、信利国际港股通持股占比增加值最大，分别增加0.12%、0.05%、0.03%；美图公司、恒生科技ETF、顺丰同城港股通持股占比减少值最大，分别减少-0.12%、-0.01%、-0.00%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1385933.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00120","02562","01606","01800","01776","00175","02160","06099","02429","00001","01783","01072","06865","02465","01709","00699","01798","02570","01257","02579","02603","09699","00775","00178","02800","03323","06693","01341","01357","00732","01952","02498","06166","00568","00638","01528","03032","02402","00496","00038","00816","01828","06990","01896","00553","00839","00035","01635","02328"],"gpt_icon":1},{"id":"2594240696","title":"每日卖空追踪 | 云顶新耀 12月24日卖空量成交10.6万股，卖空比例为4.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594240696","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594240696?lang=zh_cn&edition=full","pubTime":"2025-12-24 16:30","pubTimestamp":1766565024,"startTime":"0","endTime":"0","summary":"云顶新耀北京时间12月24日，跌3.38%，卖空量成交10.6万股，较上一交易日减少45.5%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224163356a4727f74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224163356a4727f74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1583","01952","BK1161"],"gpt_icon":0},{"id":"2594406988","title":"海南合瑞首仿布地奈德肠溶胶囊获批，云顶新耀独占被打破，IgA肾病治疗市场竞争格局重塑","url":"https://stock-news.laohu8.com/highlight/detail?id=2594406988","media":"Ofweek光电信息网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594406988?lang=zh_cn&edition=full","pubTime":"2025-12-24 16:07","pubTimestamp":1766563620,"startTime":"0","endTime":"0","summary":"12月22日，据NMPA官网显示，海南合瑞制药提交的4类仿制药布地奈德肠溶胶囊获批上市，斩获国内首仿，打破云顶新耀在igAN对因治疗市场的独占局面，重塑该领域竞争格局。2025年1月1日起布地奈德肠溶胶囊正式纳入医保报销。3家药企争先布局，海南合瑞拿下首仿目前布地奈德肠溶胶囊仅Everest Medicines进口一家企业获批。布地奈德肠溶胶囊的专利在2029年05月到期，3类专利申明表明在专利到期后仿制药即可上市销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224161452a47268a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224161452a47268a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","01952","BK1583","01093","BK1161"],"gpt_icon":0},{"id":"2593173429","title":"【券商聚焦】长江证券予云顶新耀(01952)“买入”评级 指mRNA平台突破有望打开公司长期的增长空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2593173429","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593173429?lang=zh_cn&edition=full","pubTime":"2025-12-24 13:18","pubTimestamp":1766553495,"startTime":"0","endTime":"0","summary":"金吾财讯 | 长江证券发研报指，云顶新耀 已初步构建了国际领先的、完全整合且本地化的AI+mRNA平台，聚焦高门槛肿瘤疫苗及InvivoCAR-T赛道，其三款核心产品管线通用型现货肿瘤治疗性疫苗EVM14、个性化肿瘤治疗性疫苗EVM16，以及体内自体生成CAR-TEVM18，均已进入临床或临床前关键阶段。整体来看，云顶新耀mRNA平台的突破，或将成为公司战略转型的关键推动力，有望打开公司长期的增长空间，推动公司从单纯的药品商业化主体，向技术输出型的创新企业转型。","market":"sg","thumbnail":"https://static.szfiu.com/news/20210810/NGI5ZWE4NDg5Y2ExYTk3MGU2NzMxODA4MzkxNTM=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NGI5ZWE4NDg5Y2ExYTk3MGU2NzMxODA4MzkxNTM=.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1972175","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01952","000783"],"gpt_icon":0},{"id":"2593444378","title":"智通港股通占比异动统计|12月24日","url":"https://stock-news.laohu8.com/highlight/detail?id=2593444378","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593444378?lang=zh_cn&edition=full","pubTime":"2025-12-24 08:36","pubTimestamp":1766536569,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，根据2025年12月23日披露数据，狮腾控股、均胜电子、东方电气港股通持股占比增加值最大，分别增加2.12%、1.44%、1.17%；佑驾创新、山东墨龙、浙江世宝港股通持股占比减少值最大，分别减少-1.16%、-1.09%、-0.72%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1385255.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00358","03347","06693","02648","00119","01138","02865","01057","02587","09688","00839","02570","01635","02498","01880","02465","03033","02643","06127","09696","01072","09927","02603","01357","00187","02160","00038","00638","02431","03323","03678","00568","00552","02579","01952","00175","00699","01071","01528","01341","02727","01798","01896","06166","01709","02273","02562","00553"],"gpt_icon":1},{"id":"2593456295","title":"智通港股通资金流向统计(T+2)|12月23日","url":"https://stock-news.laohu8.com/highlight/detail?id=2593456295","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593456295?lang=zh_cn&edition=full","pubTime":"2025-12-23 07:31","pubTimestamp":1766446262,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，12月18日,小米集团-W、美团-W、长飞光纤光缆南向资金净流入金额位列市场前三，分别净流入9.04 亿、4.76 亿、3.56 亿盈富基金、中国移动、信达生物南向资金净流出金额位列市场前三，分别净流出-14.20 亿、-12.95 亿、-2.71 亿在净流入比方面，南方恒指ETF、工银南方中国、美的置业以84.61%、75.00%、65.00%位列市场前三。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384684.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["81810","00363","02328","06160","01186","00107","03690","00016","03868","01258","00386","03143","01810","00388","01686","01952","00006","03121","01117","03442","03968","ALBmain","HEXmain","01093","HMTD.SI","PAImain","09985","89988","00857","03990","82318","01801","00272","03037","02800","09899","PNGAY","03167","03145","HKXCY","01288","02318","03328","06098","06869","00003","02899","00941"],"gpt_icon":1},{"id":"2593431028","title":"云顶新耀12月22日遭主力抛售839.0万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593431028","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593431028?lang=zh_cn&edition=full","pubTime":"2025-12-22 16:15","pubTimestamp":1766391340,"startTime":"0","endTime":"0","summary":"12月22日, 云顶新耀股价跌3.75%，报收47.18元，成交金额1.9亿元，换手率1.14%，振幅4.37%，量比0.78。云顶新耀今日主力资金净流出839.0万元，上一交易日主力净流出120.2万元。该股近5个交易日上涨0.64%，主力资金累计净流入896.0万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入2488.2万元，其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222161921a6c08888&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222161921a6c08888&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1161","01952","BK1574"],"gpt_icon":0},{"id":"2593888434","title":"以商业化验证价值，以平台整合资源：云顶新耀重塑创新药商业逻辑","url":"https://stock-news.laohu8.com/highlight/detail?id=2593888434","media":"医曜","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593888434?lang=zh_cn&edition=full","pubTime":"2025-12-22 07:28","pubTimestamp":1766359680,"startTime":"0","endTime":"0","summary":"正因拥有商业化“确定性引擎”的带动，云顶新耀的自主研发“成长性引擎”才会被市场寄予厚望。这一布局背后，深刻凸显了云顶新耀在商业化平台能力建设上的长远战略考量。最终，通过这一梯队化布局，云顶新耀将构建起具备长期竞争壁垒的生态护城河。当前，国内创新药行业正面临“产品同质化严重、商业化转化能","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222081630a6bed6d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222081630a6bed6d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1574","06978","BK1161","01952"],"gpt_icon":0},{"id":"2592974682","title":"云顶新耀2030战略落地：创新与全球化实力获认可","url":"https://stock-news.laohu8.com/highlight/detail?id=2592974682","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592974682?lang=zh_cn&edition=full","pubTime":"2025-12-18 17:52","pubTimestamp":1766051570,"startTime":"0","endTime":"0","summary":"日前，由数字化智库型财经媒体领跑者《21世纪经济报道》与21世纪新健康研究院发起2025年第九届21世纪大健康产业竞争力研究“阳光”案例正式揭晓。作为大健康产业领域极具权威性的年度评选成果，本次公布的案例集中展现了当下产业内的创新活力、技术突破与实践典范，为行业高质量发展树立了鲜明标杆。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512183595560991.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512183595560991.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["01952","BK1583","BK1161","BK1574"],"gpt_icon":0},{"id":"2592838922","title":"体内CAR-T赛道白热化：盘点国内19家核心企业管线全景图","url":"https://stock-news.laohu8.com/highlight/detail?id=2592838922","media":"求实药社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592838922?lang=zh_cn&edition=full","pubTime":"2025-12-18 12:02","pubTimestamp":1766030559,"startTime":"0","endTime":"0","summary":"跨国药企重磅加注，国内Biotech加速推进，体内CAR-T已成细胞治疗领域的热门赛道。这项颠覆性技术旨在解决传统CAR-T高成本、长周期的痛点，并进一步拓展血液瘤、实体瘤及自免疾病适应症。纵观国内研发格局，体内CAR-T正呈现出“技术路线多元化”与“临床验证加速化”的双重特征。从进展来看，IIT已成为当前验证体内CAR-T安全性与有效性的主战场。2025年3月完成首例患者给药，进入临床阶段，是国内较早进入体内CAR临床阶段的企业之一。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218134128a459f8ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218134128a459f8ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1574","01952","BK1161","LEGN"],"gpt_icon":0},{"id":"2592924098","title":"云顶新耀，拿下六个原研！","url":"https://stock-news.laohu8.com/highlight/detail?id=2592924098","media":"药通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592924098?lang=zh_cn&edition=full","pubTime":"2025-12-17 17:32","pubTimestamp":1765963946,"startTime":"0","endTime":"0","summary":"12月11日，云顶新耀宣布与海森生物签署两项战略合作协议，其一是6款成熟产品的商业化服务协议；其二是正在研发的PCSK9抑制剂“莱达西贝普”后续大中华区的开发、注册、商业化独家许可协议。经查，海森生物和云顶新耀背后均是康桥资本操控，此次合作可理解为左右手互助。因此云顶新耀无需显著增加成本，利用现有渠道就能创造增量。就在今日，云顶新耀宣布莱达西贝普已获FDA批准上市，EMA正处于审批中，计划2026年上半年于大中华区递交BLA。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217175309a6ad7afa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217175309a6ad7afa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","01952","BK1583","BK1161"],"gpt_icon":0},{"id":"2592924043","title":"每日卖空追踪 | 云顶新耀 12月17日卖空量成交16.7万股，卖空比例为3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592924043","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592924043?lang=zh_cn&edition=full","pubTime":"2025-12-17 16:30","pubTimestamp":1765960225,"startTime":"0","endTime":"0","summary":"云顶新耀北京时间12月17日，涨6.79%，卖空量成交16.7万股，较上一交易日减少65.24%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217163402a4561287&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217163402a4561287&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01952","BK1583","BK1574","BK1161"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.everestmedicines.com","stockEarnings":[{"period":"1week","weight":-0.1712},{"period":"1month","weight":-0.2085},{"period":"3month","weight":-0.3569},{"period":"6month","weight":-0.4493},{"period":"1year","weight":-0.236},{"period":"ytd","weight":-0.236}],"compareEarnings":[{"period":"1week","weight":-0.0073},{"period":"1month","weight":-0.0155},{"period":"3month","weight":-0.0607},{"period":"6month","weight":0.0717},{"period":"1year","weight":0.2777},{"period":"ytd","weight":0.2777}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"云顶新耀有限公司是一家主要从事创新药及疫苗研发、临床开发、制造及商业化的生物制药公司。该公司已建立跨肾病、抗感染及自身免疫性疾病的产品管线。该公司的产品管线包括用于肾病治疗领域的耐赋康（TARPEYO）、用于治疗包括临床常见的革兰氏阴性菌、革兰氏阳性菌、厌氧菌等多重耐药菌的感染的依嘉（依拉环素）等产品。该公司在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.001711},{"month":2,"riseRate":0.4,"avgChangeRate":0.052947},{"month":3,"riseRate":0.4,"avgChangeRate":0.004093},{"month":4,"riseRate":0.2,"avgChangeRate":-0.095155},{"month":5,"riseRate":0.4,"avgChangeRate":-0.02945},{"month":6,"riseRate":0.8,"avgChangeRate":0.307082},{"month":7,"riseRate":0.2,"avgChangeRate":-0.114966},{"month":8,"riseRate":0.2,"avgChangeRate":-0.112869},{"month":9,"riseRate":0.6,"avgChangeRate":0.046163},{"month":10,"riseRate":0.4,"avgChangeRate":-0.024036},{"month":11,"riseRate":0.5,"avgChangeRate":0.086142},{"month":12,"riseRate":0.666667,"avgChangeRate":0.131823}],"exchange":"SEHK","name":"云顶新耀","nameEN":"EVEREST MED"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"云顶新耀(01952)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供云顶新耀(01952)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"云顶新耀,01952,云顶新耀股票,云顶新耀股票老虎,云顶新耀股票老虎国际,云顶新耀行情,云顶新耀股票行情,云顶新耀股价,云顶新耀股市,云顶新耀股票价格,云顶新耀股票交易,云顶新耀股票购买,云顶新耀股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"云顶新耀(01952)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供云顶新耀(01952)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}